Search
for
Sort by
Research 30 of 112
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer
- Author response: Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma
- Editor's evaluation: Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma
- Decision letter: Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma
- 42761 The elusive BAP1 mutation in pediatric melanocytic tumors
- Author response: Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes
- Decision letter: Dynamics of nevus development implicate cell cooperation in the growth arrest of transformed melanocytes
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- Hair(y) Matters in Melanoma Biology
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- At the Root: Cutaneous Langerhans Cell Histiocytosis
- Dyad of infantile cutaneous and thymic Langerhans cell histiocytosis: Is it rare?
- A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Lentiginous melanoma. A clinically malignant entity that histopathologically seems benign. Case study harbouring BRAF V 600R mutation
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Management of Toxicities of Targeted Therapies
- Targeting the Warburg Effect in Anaplastic Thyroid Carcinoma: Metabolic Vulnerabilities and Therapeutic Opportunities
- Biological therapy in the treatment of melanoma
- 559 Visualization of sweat suppression following botulinum toxin A by soluble microneedle arrays
- 556 α 1 -AR agonist induced piloerection protects against the development of traction alopecia
- 557 A peptide derivative with known anti-wrinkle properties was identified as potent dipeptiylpeptidase-4 inhibitor
- Primary cicatricial alopecia and inflammatory bowel disease – is there a link?
- Nuclear Topology, Epigenetics, and Keratinocyte Differentiation